| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919510 | Radiotherapy and Oncology | 2013 | 5 Pages |
Abstract
The finding of comparable long-term QoL after SC-RT and LC-RCHT adds to our knowledge of equivalent oncological outcome and may be useful in the decision making process between the two neoadjuvant approaches.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Matthias Guckenberger, Gabriella Saur, Daniel Wehner, Andreas Thalheimer, Mia Kim, Christoph-Thomas Germer, Michael Flentje,